Consensus recommendation for India and Bangladesh for the use of pneumococcal vaccine in mass gatherings with special reference to Hajj pilgrims. Mathai, D., Shamsuzzaman, A., Feroz, A., Virani, A., Hasan, A., Ravi Kumar, K., Ansari, K., Forhad Hossain, K., Marda, M., Wahab Zubair, M., Ali, M., Ashraf, N., Basha, R., Mirza, S., Ahmed, S., Akhtar, S., Ashraf, S., & Haque, Z. Journal of Global Infectious Diseases, 8(4):129–138, 2016.
Consensus recommendation for India and Bangladesh for the use of pneumococcal vaccine in mass gatherings with special reference to Hajj pilgrims [link]Paper  doi  abstract   bibtex   
Respiratory tract infections are prevalent among Hajj pilgrims with pneumonia being a leading cause of hospitalization. Streptococcus pneumoniae is a common pathogen isolated from patients with pneumonia and respiratory tract infections during Hajj. There is a significant burden of pneumococcal disease in India, which can be prevented. Guidelines for preventive measures and adult immunization have been published in India, but the implementation of the guidelines is low. Data from Bangladesh are available about significant mortality due to respiratory infections; however, literature regarding guidelines for adult immunization is limited. There is a need for extensive awareness programs across India and Bangladesh. Hence, there was a general consensus about the necessity for a rapid and urgent implementation of measures to prevent respiratory infections in pilgrims traveling to Hajj. About ten countries have developed recommendations for pneumococcal vaccination in Hajj pilgrims: France, the USA, Kuwait, Qatar, Bahrain, the UAE (Dubai Health Authority), Singapore, Malaysia, Egypt, and Indonesia. At any given point whether it is Hajj or Umrah, more than a million people are present in the holy places of Mecca and Madina. Therefore, the preventive measures taken for Hajj apply for Umrah as well. This document puts forward the consensus recommendations by a group of twenty doctors following a closed-door discussion based on the scientific evidence available for India and Bangladesh regarding the prevention of respiratory tract infections in Hajj pilgrims.Copyright © 2016 Journal of Global Infectious Diseases Published by Wolters Kluwer - Medknow.
@article{mathai_consensus_2016,
	title = {Consensus recommendation for {India} and {Bangladesh} for the use of pneumococcal vaccine in mass gatherings with special reference to {Hajj} pilgrims},
	volume = {8},
	issn = {0974-777X 0974-8245},
	url = {http://www.jgid.org/ http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed17&NEWS=N&AN=613248219},
	doi = {10.4103/0974-777X.193749},
	abstract = {Respiratory tract infections are prevalent among Hajj pilgrims with pneumonia being a leading cause of hospitalization. Streptococcus pneumoniae is a common pathogen isolated from patients with pneumonia and respiratory tract infections during Hajj. There is a significant burden of pneumococcal disease in India, which can be prevented. Guidelines for preventive measures and adult immunization have been published in India, but the implementation of the guidelines is low. Data from Bangladesh are available about significant mortality due to respiratory infections; however, literature regarding guidelines for adult immunization is limited. There is a need for extensive awareness programs across India and Bangladesh. Hence, there was a general consensus about the necessity for a rapid and urgent implementation of measures to prevent respiratory infections in pilgrims traveling to Hajj. About ten countries have developed recommendations for pneumococcal vaccination in Hajj pilgrims: France, the USA, Kuwait, Qatar, Bahrain, the UAE (Dubai Health Authority), Singapore, Malaysia, Egypt, and Indonesia. At any given point whether it is Hajj or Umrah, more than a million people are present in the holy places of Mecca and Madina. Therefore, the preventive measures taken for Hajj apply for Umrah as well. This document puts forward the consensus recommendations by a group of twenty doctors following a closed-door discussion based on the scientific evidence available for India and Bangladesh regarding the prevention of respiratory tract infections in Hajj pilgrims.Copyright © 2016 Journal of Global Infectious Diseases Published by Wolters Kluwer - Medknow.},
	language = {English},
	number = {4},
	journal = {Journal of Global Infectious Diseases},
	author = {Mathai, D. and Shamsuzzaman, A. and Feroz, A. and Virani, A. and Hasan, A. and Ravi Kumar, K. and Ansari, K. and Forhad Hossain, K. and Marda, M. and Wahab Zubair, M. and Ali, M. and Ashraf, N. and Basha, R. and Mirza, S. and Ahmed, S. and Akhtar, S. and Ashraf, S. and Haque, Z.},
	year = {2016},
	keywords = {*Hajj pilgrim, *Pneumococcus vaccine, *consensus development, *travel, *vaccination, Bangladesh, India, Saudi Arabia, article, bacterial transmission, community acquired pneumonia, drug use, geographic distribution, health care cost, health program, health service, human, infection prevention, morbidity, mortality, pneumococcal infection/ep [Epidemiology], population distribution, priority journal, religion, respiratory tract infection, risk assessment, risk factor, strategic planning},
	pages = {129--138}
}
Downloads: 0